NCT03172598View on ClinicalTrials.gov

Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

July 25, 2017

Primary Completion Date

August 8, 2018

Study Completion Date

August 8, 2018

Conditions
Painful Diabetic Peripheral Neuropathy
Interventions
DRUG

MT-8554 low dose

Capsule

DRUG

MT-8554 middle dose

Capsule

DRUG

MT-8554 high dose

Capsule

DRUG

Placebo

Capsule

Trial Locations (3)

Unknown

Investigational center, City Name

Investigational center, City Name

Investigational center, City Name

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY